Japan’s general trading houses are steadily becoming a force to be reckoned with in the pharmaceutical industry — and not…
HOME > LATEST
LATEST
-
ORGANIZATION Labor Union Calls for Uniform Hike in Drug Prices, Lawmakers Urge Overhaul
October 29, 2025
-
BUSINESS J-TEC, AlliedCel Ink Service Contract for T-Cell Therapy Production
October 29, 2025
-
BUSINESS Japan Gives Orphan Tags for Kyowa Kirin’s Gene Therapy, Cuorips’ Cell Sheet
October 29, 2025
-
REGULATORY Japan PM Warns of Overreliance on China for Pharmaceutical Ingredients
October 29, 2025
-
REGULATORY Public-Private WG’s Discussion Summary Focuses on Drug Pricing, Raises MFN Risk
October 29, 2025
-
BUSINESS NEC Crafts Data Platform to Advance Personalized Cancer Vaccine Program
October 28, 2025
-
BUSINESS Shionogi Sees Flat 1H Results, Gains Domestic Support from Torii
October 28, 2025
-
BUSINESS Novo to End Sales of Victoza in Japan, Fourth GLP-1 to Exit Market
October 28, 2025
-
BUSINESS Eisai, Biogen Win Conditional Nod for Leqembi in Canada
October 28, 2025
-
BUSINESS J&J Files for 4-Week SC Dosing of Rybrevant in Japan
October 28, 2025
-
BUSINESS Viatris Begins Japan Enrollment in Global PIII Study for AMI Drug
October 28, 2025
-
REGULATORY Japan Finalizes Designation of 762 “Supply-Ensured Medicines”
October 28, 2025
-
BUSINESS Medinet Grabs Option for Stempeucel from India’s Stempeutics
October 28, 2025
-
BUSINESS Japan Ethical Drug Sales Rise 2.8% in April-September: Encise
October 28, 2025
-
BUSINESS First Oral Small-Molecule GLP-1 Nears Filing; Broad Use Expected in Diabetes
October 27, 2025
-
BUSINESS Chugai Acquires Renalys Pharma, Bags IgAN Drug
October 27, 2025
-
REGULATORY Takaichi Vows Cross-Party Talks on Social Security Reform
October 27, 2025
-
BUSINESS Astellas to Build Next-Gen Pipeline in I/O and Protein Degradation: R&D Chief
October 27, 2025
-
COMMENTARY The Price of Stability: Who Bears Japan’s Drug Distribution Burden?
October 27, 2025
-
REGULATORY Chuikyo Members Call for Revising Clozapine Fee Criteria to “Hospital-Based” Calculation
October 27, 2025
ページ
A public-private council report outlining industry views on Japan’s drug pricing systems drew little discussion at a meeting of the…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
In the complex tapestry of leadership, awareness isn’t just a desirable trait; it’s the bedrock upon which success is built. It’s the lens through which leaders perceive, interpret, and navigate the ever-shifting landscape of their organizations and industries. Without it,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…